Tax Inversion Laws Won't Tank This Deal

The U.S. government implemented a new tax inversion rule to clamp down on companies that attempt to reduce tax bills by merging with foreign firms and relocating headquarters overseas. The new rule sounds nice on the surface, but it could ultimately do more harm than good - especially to your portfolio. Here's why - plus one deal this law can't tank... Tags: anti-inversion law , Pfizer Allergan deal , tax inversion , tax inversion law To get full access to all Money Morning content, click here About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free . Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and visitors become smarter, more confident investors. Disclaimer: © 2016 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201. The post Tax Inversion Laws Won't Tank This Deal appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.